Biomarker evaluation uncovers uncertain utility of eosinophil peroxidase relative to cell counts in asthma, highlighting the need for clinical validation.
The relative utility of eosinophil peroxidase (EPX) and blood and sputum eosinophil counts as disease biomarkers in asthma is uncertain.
No takes yet. Share an insight, caveat, or question.
Tang et al. (2024) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: